Skip to main content
Log in

Required cefazolin concentration to maximize diagnostic accuracy of the basophil activation test for cefazolin-induced anaphylaxis

  • Original Article
  • Published:
Journal of Anesthesia Aims and scope Submit manuscript

Abstract

Purpose

Identifying the causative agent of perioperative anaphylaxis is key to preventing its recurrence. Besides skin testing, the basophil activation test (BAT) is increasingly being accepted as an additional and reliable method. Cefazolin seems to be a major cause of perioperative anaphylaxis. However, few studies have described use of the BAT for cefazolin-induced anaphylaxis. In this study, we aimed to determine the optimum cefazolin concentration required in the BAT for an accurate diagnosis.

Methods

Seven patients who presented with immediate hypersensitivity to cefazolin and 21 control subjects were studied. We conducted skin tests and performed BATs using both CD203c and CD63 as markers of activated basophils. We measured the ratio of activated basophils after stimulation with serial dilutions of cefazolin and investigated the cefazolin concentration that resulted in better sensitivity and specificity.

Results

All patients demonstrated positive reactions to cefazolin, while all control subjects showed negative reactions on skin tests. The net percentage of both CD203c- and CD63-labeled activated basophils was greater when higher concentrations of cefazolin than previously reported were used. In control subjects, however, the number of activated basophils by cefazolin stimulation was negligible regardless of its concentration. In the case of CD203c, the sensitivity was 86% with a cefazolin concentration of 3 mg/ml, while in the case of CD63, the sensitivity was 100% with a cefazolin concentration of 10 mg/ml.

Conclusion

Using a higher concentration of cefazolin than previously reported for the BAT might increase the accuracy of diagnosis of cefazolin-induced anaphylaxis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Mertes PM, Malinovsky JM, Jouffroy L, Working Group of the SFAR and SFA, Aberer W, Terreehorst I, Brockow K, Demoly P, ENDA, EAACI Interest Group on Drug Allergy. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J Investig Allergol Clin Immunol. 2011;21(6):442–53.

    CAS  PubMed  Google Scholar 

  2. Dong SW, Mertes PM, Petitpain N, Hasdenteufel F, Malinovsky JM, GERAP. Hypersensitivity reactions during anesthesia. Results from the ninth French survey (2005–2007). Minerva Anestesiol. 2012;78(8):868–78.

    CAS  PubMed  Google Scholar 

  3. Lobera T, Audicana MT, Pozo MD, Blasco A, Fernandez E, Canada P, Gastaminza G, Martinez-Albelda I, González-Mahave I, Muñoz D. Study of hypersensitivity reactions and anaphylaxis during anesthesia in Spain. J Investig Allergol Clin Immunol. 2008;18(5):350–6.

    CAS  PubMed  Google Scholar 

  4. Gurrieri C, Weingarten TN, Martin DP, Babovic N, Narr BJ, Sprung J, Volcheck GW. Allergic reactions during anesthesia at a large United States referral center. Anesth Analg. 2011;113(5):1202–12.

    Article  CAS  Google Scholar 

  5. Gonzalez-Estrada A, Pien LC, Zell K, Wang XF, Lang DM. Antibiotics are an important identifiable cause of perioperative anaphylaxis in the United States. J Allergy Clin Immunol Pract. 2015;3(1):101–5.e1.

    Article  Google Scholar 

  6. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR, Guideline for Prevention of Surgical Site Infection. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999;27(2):97–132 (quiz 3–4; discussion 96).

    Article  CAS  Google Scholar 

  7. Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, Fish DN, Napolitano LM, Sawyer RG, Slain D, Steinberg JP, Weinstein RA, American Society of Health-System Pharmacists, Infectious Disease Society of America, Surgical Infection Society, Society for Healthcare Epidemiology of America. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect. 2013;14(1):73–156.

    Article  Google Scholar 

  8. Uyttebroek AP, Decuyper II, Bridts CH, Romano A, Hagendorens MM, Ebo DG, Sabato V. Cefazolin hypersensitivity: toward optimized diagnosis. J Allergy Clin Immunol Pract. 2016;4(6):1232–36.

    Article  Google Scholar 

  9. Mayorga C, Sanz ML, Gamboa PM, Garcia BE, Caballero MT, Garcia JM, Labrador M, Lahoz C, Longo Areso N, López Hoyos M, Martínez Quesada J, Monteseirín FJ, Immunology Committee of the Spanish Society of Allergology and Clinical Immunology of the SEAIC. In vitro diagnosis of immediate allergic reactions to drugs: an update. J Investig Allergol Clin Immunol. 2010;20(2):103–9.

    CAS  PubMed  Google Scholar 

  10. Co Minh HB, Bousquet PJ, Fontaine C, Kvedariene V, Demoly P. Systemic reactions during skin tests with beta-lactams: a risk factor analysis. J Allergy Clin Immunol. 2006;117(2):466–8.

    Article  Google Scholar 

  11. Valyasevi MA, Maddox DE, Li JT. Systemic reactions to allergy skin tests. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 1999;83(2):132–6.

    Article  CAS  Google Scholar 

  12. Valyasevi MA, Van Dellen RG. Frequency of systematic reactions to penicillin skin tests. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2000;85(5):363–5.

    Article  CAS  Google Scholar 

  13. Sellaturay P, Nasser S, Ewan P. The incidence and features of systemic reactions to skin prick tests. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2015;115(3):229–33.

    Article  Google Scholar 

  14. Yamaoka M, Deguchi M, Ninomiya K, Kurasako T, Matsumoto M. A suspected case of rocuronium-sugammadex complex-induced anaphylactic shock after cesarean section. J Anesth. 2017;31(1):148–51.

    Article  Google Scholar 

  15. Uyttebroek AP, Sabato V, Cop N, Decuyper II, Faber MA, Bridts CH, Mertens C, Hagendorens MM, De Clerck LS, Ebo DG. Diagnosing cefazolin hypersensitivity: lessons from dual-labeling flow cytometry. J Allergy Clin Immunol Pract. 2016;4(6):1243–5.

    Article  CAS  Google Scholar 

  16. Leysen J, Sabato V, Verweij MM, De Knop KJ, Bridts CH, De Clerck LS, Ebo DG. The basophil activation test in the diagnosis of immediate drug hypersensitivity. Expert Rev Clin Immunol. 2011;7(3):349–55.

    Article  CAS  Google Scholar 

  17. Ebo DG, Bridts CH, Hagendorens MM, Mertens CH, De Clerck LS, Stevens WJ. Flow-assisted diagnostic management of anaphylaxis from rocuronium bromide. Allergy. 2006;61(8):935–9.

    Article  CAS  Google Scholar 

  18. Uyttebroek AP, Sabato V, Leysen J, Bridts CH, De Clerck LS, Ebo DG. Flowcytometric diagnosis of atracurium-induced anaphylaxis. Allergy. 2014;69(10):1324–32.

    Article  CAS  Google Scholar 

  19. Horiuchi T, Yokohama A, Orihara M, Tomita Y, Tomioka A, Yoshida N, Takahashi K, Saito S, Takazawa T. Usefulness of basophil activation tests for diagnosis of sugammadex-induced anaphylaxis. Anesth Analg. 2018;126(5):1509–16.

    Article  CAS  Google Scholar 

  20. Aranda A, Mayorga C, Ariza A, Dona I, Blanca-Lopez N, Canto G, Blanca M, Torres MJ. IgE-mediated hypersensitivity reactions to methylprednisolone. Allergy. 2010;65(11):1376–80.

    Article  CAS  Google Scholar 

  21. Aranda A, Mayorga C, Ariza A, Dona I, Rosado A, Blanca-Lopez N, Andreu I, Torres MJ. In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones. Allergy. 2011;66(2):247–54.

    Article  CAS  Google Scholar 

  22. Uyttebroek AP, Sabato V, Faber MA, Cop N, Bridts CH, Lapeere H, De Clerck LS, Ebo DG. Basophil activation tests: time for a reconsideration. Expert Rev Clin Immunol. 2014;10(10):1325–35.

    Article  CAS  Google Scholar 

  23. Song WJ, Chang YS. Recent applications of basophil activation tests in the diagnosis of drug hypersensitivity. Asia Pac Allergy. 2013;3(4):266–80.

    Article  Google Scholar 

  24. Torres MJ, Ariza A, Fernandez J, Moreno E, Laguna JJ, Montanez MI, Ruiz-Sanchez AJ, Blanca M. Role of minor determinants of amoxicillin in the diagnosis of immediate allergic reactions to amoxicillin. Allergy. 2010;65(5):590–6.

    Article  CAS  Google Scholar 

  25. Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy. 2002;57(1):45–51.

    CAS  PubMed  Google Scholar 

  26. Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, Bircher A, Blanca M, Bonadonna B, Campi P, Castro E, Cernadas JR, Chiriac AM, Demoly P, Grosber M, Gooi J, Lombardo C, Mertes PM, Mosbech H, Nasser S, Pagani M, Ring J, Romano A, Scherer K, Schnyder B, Testi S, Torres M, Trautmann A, Terreehorst I, ENDA/EAACI Drug Allergy Interest Group. Skin test concentrations for systemically administered drugs—an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy. 2013;68(6):702–12.

    Article  CAS  Google Scholar 

  27. Barbaud A, Goncalo M, Bruynzeel D, Bircher A. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermat. 2001;45(6):321–8.

    Article  CAS  Google Scholar 

  28. Takazawa T, Horiuchi T, Yoshida N, Yokohama A, Saito S. Flow cytometric investigation of sugammadex-induced anaphylaxis. Br J Anaesth. 2015;114(5):858–9.

    Article  CAS  Google Scholar 

  29. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet. 1977;1(8009):466–9.

    Article  CAS  Google Scholar 

  30. Blanca M, Romano A, Torres MJ, Férnandez J, Mayorga C, Rodriguez J, Demoly P, Bousquet PJ, Merk HF, Sanz ML, Ott H, Atanasković-Marković M. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy. 2009;64(2):183–93.

    Article  CAS  Google Scholar 

  31. Ebo DG, Faber M, Elst J, Van Gasse AL, Bridts CH, Mertens C, De Clerck LS, Hagendorens MM, Sabato V. In vitro diagnosis of immediate drug hypersensitivity during anesthesia: a review of the literature. J Allergy Clin Immunol Pract. 2018;6(4):1176–84.

    Article  Google Scholar 

  32. Ebo DG, Leysen J, Mayorga C, Rozieres A, Knol EF, Terreehorst I. The in vitro diagnosis of drug allergy: status and perspectives. Allergy. 2011;66(10):1275–86.

    Article  CAS  Google Scholar 

  33. Marinho S, Kemp H, Cook TM, Farmer L, Farooque S, Lucas DN, Garcez T, Floss K, Torevell H, Thomas M, Warner A, Hitchman J, Ferguson K, Egner W, Nasser S, Karanam S, Kong KL, McGuire N, Bellamy M, Harper NJN. Cross-sectional study of perioperative drug and allergen exposure in UK practice in 2016: the 6th National Audit Project (NAP6) Allergen Survey. Br J Anaesth. 2018;121(1):146–58.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr. Kenzaburo Sugimoto of the Department of Anesthesiology, Jichi University Hospital, for his kind advice regarding the skin tests. This study was supported by JSPS KAKENHI Grant numbers JP 16M02678 and 15K10533, and the Kosaka Rinsyo Masui Fund.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tatsuo Horiuchi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Horiuchi, T., Takazawa, T., Orihara, M. et al. Required cefazolin concentration to maximize diagnostic accuracy of the basophil activation test for cefazolin-induced anaphylaxis. J Anesth 32, 797–805 (2018). https://doi.org/10.1007/s00540-018-2555-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00540-018-2555-z

Keywords

Navigation